ZEVRA THERAPEUTICS INC (ZVRA)
US4884452065 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 28.65M 115.58% | 10.46M -63.49% | 27.461M 162.53% | 20.793M -24.28% | 99.102M 376.61% | 174.64M 76.22% | 275.53M 57.77% | 351.07M 27.42% | 377.22M 7.45% | 412M 9.22% | 466.94M 13.33% | |
| EBITDA YoY % growth | 7.99M 262.07% | -23.91M -399.25% | -48.598M -103.25% | -79.764M -64.13% | -20.808M 73.91% | 28.968M 239.22% | 127.5M 340.14% | 262.14M 105.60% | 352.1M 34.32% | 499.19M 41.78% | 635.46M 27.30% | |
| EBIT YoY % growth | 7.73M 248.65% | -24.85M -421.47% | -49.604M -99.61% | -92.88M -87.24% | -15.458M 83.36% | 49.749M 421.82% | 143.95M 189.35% | 210.53M 46.25% | 238.09M 13.09% | 266.19M 11.80% | 310.45M 16.63% | |
| Operating Margin | 26.98% | -237.57% | -180.63% | -446.69% | -15.60% | 28.49% | 52.24% | 59.97% | 63.12% | 64.61% | 66.49% | |
| EPS YoY % growth | -0.46 86.10% | -0.69 -50.00% | -1.29 -86.96% | -1.96 -51.80% | -0.44 77.42% | 0.61 238.76% | 2.24 265.46% | 3.02 34.85% | 3.56 17.81% | 3.83 7.39% | 4.36 13.87% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.43 -6.52% | 0.01 103.57% | -0.20 58.35% | -0.14 79.30% | -0.07 82.76% | 0.06 328.57% | 0.16 181.63% | 0.14 200.00% | 0.19 363.89% |
| Revenue Q2Q % growth | 8.894M -32.71% | 27.606M 706.01% | 19.024M 327.60% | 22.798M 517.00% | 27.362M 207.65% | 40.888M 48.11% | 44.414M 133.46% | 47.044M 106.35% | 48.816M 78.41% |
| EBITDA Q2Q % growth | -23.562M -72.43% | -8.262M 56.34% | -5.814M 71.87% | -3.978M 82.37% | -2.754M 88.31% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -21.024M -43.30% | 2.411M 111.77% | -9.745M 59.04% | -6.895M 74.75% | -3.213M 84.72% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.69 -72.50% | -0.43 | -0.26 | -60.59% |
| Q2 2024 Q2Q % growth | -0.48 -220.00% | -0.44 | -0.04 | -8.43% |
| Q1 2024 Q2Q % growth | -0.40 -17.65% | -0.49 | 0.09 | 17.96% |
| Q4 2023 Q2Q % growth | -0.40 -53.85% | -0.27 | -0.13 | -46.15% |
| Q3 2023 Q2Q % growth | -0.40 -110.53% | -0.30 | -0.10 | -31.82% |
| Q2 2023 Q2Q % growth | -0.15 21.05% | -0.35 | 0.20 | 57.17% |
| Q1 2023 Q2Q % growth | -0.34 -580.00% | -0.24 | -0.10 | -43.37% |
| Q4 2022 Q2Q % growth | -0.26 -225.00% | -0.18 | -0.08 | -47.06% |
| Q3 2022 Q2Q % growth | -0.19 -280.00% | -0.13 | -0.06 | -43.29% |
| Q2 2022 Q2Q % growth | -0.19 -190.48% | -0.12 | -0.07 | -55.23% |
| Q1 2022 Q2Q % growth | -0.05 90.74% | -0.06 | 0.01 | 10.87% |
| Q4 2021 Q2Q % growth | -0.08 92.52% | -0.08 | 0.00 | -4.58% |
| Q3 2021 Q2Q % growth | -0.05 92.19% | -0.08 | 0.03 | 34.64% |
| Q2 2021 Q2Q % growth | 0.21 31.25% | 0.23 | -0.02 | -8.50% |
| Q1 2021 Q2Q % growth | -0.54 69.32% | -0.17 | -0.37 | -211.42% |
| Q4 2020 Q2Q % growth | -1.07 -568.75% | -0.65 | -0.42 | -63.91% |
| Q3 2020 Q2Q % growth | -0.64 -166.67% | -0.82 | 0.18 | 21.57% |
| Q2 2020 Q2Q % growth | 0.16 103.03% | 0.00 | 0.16 | % |
| Q1 2020 Q2Q % growth | -1.76 76.09% | 0.16 | -1.92 | -1,178.43% |
| Q4 2019 Q2Q % growth | -0.16 95.00% | -1.39 | 1.23 | 88.47% |
| Q3 2019 Q2Q % growth | 0.96 106.38% | -3.05 | 4.01 | 131.51% |
| Q2 2019 Q2Q % growth | -5.28 63.74% | -6.94 | 1.66 | 23.88% |
| Q1 2019 Q2Q % growth | -7.36 74.01% | -7.51 | 0.15 | 1.96% |
| Q4 2018 Q2Q % growth | -3.20 | -8.61 | 5.41 | 62.83% |
| Q3 2018 Q2Q % growth | -15.04 | -12.57 | -2.47 | -19.68% |
| Q2 2018 Q2Q % growth | -14.56 | -15.73 | 1.17 | 7.45% |
| Q1 2018 Q2Q % growth | -28.32 | -11.38 | -16.94 | -148.79% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 3.695M 27.63% | 4.966M | -1.271M | -25.59% |
| Q2 2024 Q2Q % growth | 4.449M -47.47% | 4.443M | 6K | 0.14% |
| Q1 2024 Q2Q % growth | 3.425M 18.96% | 3.839M | -414K | -10.78% |
| Q4 2023 Q2Q % growth | 13.217M 469.70% | 11.973M | 1.244M | 10.39% |
| Q3 2023 Q2Q % growth | 2.895M 0.87% | 3.447M | -552K | -16.01% |
| Q2 2023 Q2Q % growth | 8.47M 551.54% | 3.094M | 5.376M | 173.76% |
| Q1 2023 Q2Q % growth | 2.879M -27.48% | 2.708M | 171K | 6.31% |
| Q4 2022 Q2Q % growth | 2.32M -10.08% | 3.264M | -944K | -28.92% |
| Q3 2022 Q2Q % growth | 2.87M 45.69% | 3.264M | -394K | -12.07% |
| Q2 2022 Q2Q % growth | 1.3M -89.16% | 1.836M | -536K | -29.19% |
| Q1 2022 Q2Q % growth | 3.97M -67.24% | 3.126M | 844K | 27.00% |
| Q4 2021 Q2Q % growth | 2.58M 8.86% | 2.28M | 300K | 13.16% |
| Q3 2021 Q2Q % growth | 1.97M 2.07% | 2.228M | -258K | -11.58% |
| Q2 2021 Q2Q % growth | 11.99M 73.52% | 12.342M | -352K | -2.85% |
| Q1 2021 Q2Q % growth | 12.12M 479.90% | 2.142M | 9.978M | 465.83% |
| Q4 2020 Q2Q % growth | 2.37M 71.74% | 2.04M | 330K | 16.18% |
| Q3 2020 Q2Q % growth | 1.93M -83.16% | 1.938M | -8K | -0.41% |
| Q2 2020 Q2Q % growth | 6.91M | 6.885M | 25K | 0.36% |
| Q1 2020 Q2Q % growth | 2.09M | 5.916M | -3.826M | -64.67% |
| Q4 2019 Q2Q % growth | 1.38M | 5.66M | -4.28M | -75.62% |
| Q3 2019 Q2Q % growth | 11.46M | 2.992M | 8.468M | 283.02% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -94.28% | -94.28% | -14.86% | -19.8% |
| Revenue | -44.36% | -44.36% | -12.92% | -23.99% |